info@strategicmarketresearch.com
26, Broadway, Suite 934, New York , 10004
United States Flag  US: +1-315-636-4233    United Kingdom Flag  UK: +44-162-237-0614    Indian Flag  IN: +91-826-083-6500
Home » Healthcare

Healthcare

Digital Wound Care Management System Market By Product Type (Wound Care Devices, Software Solutions, Data Analytics Tools); By Application (Chronic Wounds, Acute Wounds, Burns); By End-User (Hospitals, Home Healthcare Providers, Long-Term Care Facilities, Outpatient Surgical Centers); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction and Strategic Context

The Digital Wound Care Management System market is on a growth trajectory, with an expected CAGR of 11.4% from 2024 to 2030. The market was valued at approximately US... Read More

Published Date: JUL-2025 | No Of Pages:150 | $ 4485

AI in Oncology Market By Solution Type (Diagnostic Algorithms, Treatment Planning and Decision Support, Predictive Analytics & Outcomes Monitoring, Operational AI); By Cancer Type (Breast, Lung, Colorectal, Prostate, Other); By End User (Hospitals & Cancer Centers, Diagnostic Laboratories, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction and Strategic Context for the AI in Oncology Market (2024–2030).

The Global Ai In Oncology Market will witness a robust CAGR of 23.5%, valued at $3.2 billion in 2024, expected to appreciate ... Read More

Published Date: JUL-2025 | No Of Pages:150 | $ 4485

Human Immunodeficiency Virus (HIV) Therapeutics Market By Product Type (Antiretroviral Drugs, Combination Therapies, Long-Acting Injectables, Gene Therapy & Cell-Based Therapy); By Therapy Class (NRTIs, NNRTIs, PIs, Integrase Inhibitors); By End-User (Hospitals, Specialized Clinics, Home Healthcare, Research Institutions); By Region (North America, Europe, Asia Pacific, LAMEA); Segment Revenue Estimation, Forecast, 2024–2030

Introduction and Strategic Context

The Global Human Immunodeficiency Virus (HIV) Therapeutics Market is expected to grow at a robust compound annual growth rate (CAGR) of 6.8%, with an estimated value of $31.4 billion in 2024<... Read More

Published Date: JUL-2025 | No Of Pages:150 | $ 4485

Hemoglobinopathies Market By Disease Type (Sickle Cell Disease, Beta-Thalassemia, Alpha-Thalassemia, Hemoglobin E Disorders); By Therapy Type (Supportive Care, Disease-Modifying Therapies, Gene Therapy & Curative Approaches); By Diagnostic Method (Hemoglobin Electrophoresis, HPLC, Molecular Genetic Testing, Point-of-Care Tests); By End User (Hospitals, Diagnostic Laboratories, Research Institutions, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Hemoglobinopathies Market Introduction and Strategic Context

The Global Hemoglobinopathies Market will witness a robust CAGR of 7.8%, valued at $8.9 billion in 2024, expected to appreciate and reach $14.0 billion by 2030, confirms Strategic Market Research.

... Read More

Published Date: JUN-2025 | No Of Pages:150 | $ 4485

Neurorehabilitation Devices Market By Product Type (Robotic Rehabilitation Devices, Wearable Neurorehabilitation Devices, Non-Invasive Brain Stimulation Devices, Therapeutic Gaming and Virtual Reality Systems, Others); By Application (Stroke Rehabilitation, Parkinson’s Disease Rehabilitation, Traumatic Brain Injury Rehabilitation, Spinal Cord Injury Rehabilitation, Multiple Sclerosis Rehabilitation, Others); By End User (Hospitals and Clinics, Rehabilitation Centers, Home Care Settings, Academic and Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction and Strategic Context

The Global Neurorehabilitation Devices Market is projected to witness a robust CAGR of 9.8%, valued at approximately USD 2.35 billion in 2024, and expected to appreciate and reach around USD 4.16 billion by 2030, confirms Strategic M... Read More

Published Date: JUN-2025 | No Of Pages:150 | $ 4485

Pneumonia Testing Market By Test Type (Blood Tests, Sputum Tests, Urine Antigen Tests, PCR Tests, Imaging Tests); By Technology (Immunodiagnostics, Molecular Diagnostics, Point-of-Care Testing, Culture Techniques); By End User (Hospitals, Diagnostic Laboratories, Clinics, Home Care); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction and Strategic Context

The Global Pneumonia Testing Market will witness a robust CAGR of 7.8%, valued at $2.15 billion in 2024, expected to appreciate and reach $3.40 billion by 2030, conf... Read More

Published Date: JUN-2025 | No Of Pages:150 | $ 4485

E.Coli Testing Market By Testing Method (Culture-Based Methods, Rapid Molecular Diagnostics, Immunoassays, Chromogenic Media); By Application (Clinical Diagnostics, Food Testing, Environmental Testing); By End User (Diagnostic Laboratories, Food Processing Companies, Hospitals & Clinics, Research & Academic Institutions, Government & Regulatory Bodies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction and Strategic Context

The Global E.Coli Testing Market is poised for significant growth, with a robust CAGR of 6.9% projected for the forecast period 2024–2030. Valued at approximately USD 1.6 billion in 2024, the market is anticipated to expand sig... Read More

Published Date: JUN-2025 | No Of Pages:150 | $ 4485

Precision Oncology Market By Product Type (Diagnostics, Therapeutics); By Technology (NGS, PCR, IHC, ISH, AI/ML); By Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Blood Cancer, Others); By End User (Hospitals & Clinics, Diagnostic Laboratories, Academic Institutes, Pharma & Biotech); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction and Strategic Context

The Global Precision Oncology Market will witness a robust CAGR of 11.3%, valued at $89.7 billion in 2024, and is expected to appreciate and reach $170.6 billion by 2030Read More

Published Date: JUN-2025 | No Of Pages:150 | $ 4485

AI in Prostate Cancer Diagnostics Market By Component (Software, Hardware, Services); By Diagnostic Approach (Radiology, Pathology, Genomics, Clinical Data Integration); By End User (Hospitals, Labs, Academic Institutes); By Deployment Mode (On-Premise, Cloud-Based); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction and Strategic Context

The Global AI In Prostate Cancer Diagnostics Market is projected to grow at a robust CAGR of 21.4%, valued at approximately $1.2 billion in 2024, and is expected to reach around Read More

Published Date: JUN-2025 | No Of Pages:150 | $ 4485

Anesthesia Drugs Market By Type (General Anaesthetics [Propofol, Sevoflurane, Desflurane, Dexmedetomidine, Remifentanil, Midazolam], Local Anaesthetics [Bupivacaine, Ropivacaine, Lidocaine, Chloroprocaine, Articaine, Benzocaine]); By Application (General Surgeries, Plastic Surgery, Cosmetic Surgeries, Dental Surgeries); By Route Of Administration (Inhalation Anesthesia Drugs, Intravenous Anesthesia Drugs, Topical Anesthesia Drugs); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

Anesthesia Drugs Market Overview:

The Anesthesia Drugs Market was valued at USD 6.8 billion in 2020, is projected to reach approximately USD 7.81 billion by 2024, and is expected to grow further to around USD 9.60 billion by 2030, expanding at a CAGR of approximately ... Read More

Published Date: JUN-2025 | No Of Pages:150 | $ 4485